Patients relying on a temporary heart pump to stay alive face a direct threat: the FDA classified a recall of Abiomed’s ...

There are new and revised warnings about the instructions for use of a certain type of heart pump that could lead to a risk of heart perforation, according to an alert issued by the pump’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Impella CP heart pump in an illustration of the heart. Johnson & Johnson’s Impella heart pump failed to lower ...

A new type of surgically implanted pump that can support a child's failing heart has passed the first stage of human testing in a recent trial. A small, implantable cardiac pump that could help ...

An international trial of the Impella heart pump in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock has been stopped by the sponsor Abiomed, Inc. The termination ...

The Food and Drug Administration issued its highest-level alert this month about a heart pump associated with reports of 49 deaths and dozens of serious injuries, sharing updated instructions from the ...

Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to heart pump treatments and are left with only medication or palliative care.

Temporary mechanical circulatory support (MCS) devices augment the output of a failing heart: they are intended to assist with the pumping function of the heart for a period of up to several days, ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...